Only weeks after Mats Brännström gave his key-note lecture at the annual ESGE conference in Brussels, the Lancet pub-lishes a case observation of the first live born baby following uterine transplantation [1]. On his last slide, he forecasted livebirths within a year. Most must have thought this was a realistic forecast; the audience could not know that his confi-dence may have indicated that an imminent report was still under embargo, hence too early to share this news with the nearly 2000 congress participants. The first live born baby after uterine transplantation rewards over 15 years of meticu-lous and robust research by the team from Göteborg, Sweden. The enterprise was considered as the last frontier in fertility treatment, hence breached in 2014. The many women facing
infertility due to absence of a (functional) uterus may now rightfully get hope by this fantastic news. Also the surgical community should be stunned by such technical accomplish-ment, thoughwe invite you to look through the headlines, and see it as an exemplary demonstration how surgical innovation should be introduced